Copeland Capital Management LLC Has $91.71 Million Holdings in Chemed Corporation (NYSE:CHE)

Copeland Capital Management LLC lowered its holdings in Chemed Corporation (NYSE:CHE - Free Report) by 1.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,035 shares of the company's stock after selling 2,588 shares during the quarter. Chemed accounts for about 1.8% of Copeland Capital Management LLC's investment portfolio, making the stock its 6th largest position. Copeland Capital Management LLC owned about 1.02% of Chemed worth $91,705,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Norges Bank acquired a new stake in Chemed in the 4th quarter valued at approximately $95,872,000. GAMMA Investing LLC raised its stake in shares of Chemed by 131,200.8% in the first quarter. GAMMA Investing LLC now owns 166,752 shares of the company's stock valued at $102,606,000 after purchasing an additional 166,625 shares in the last quarter. Freestone Grove Partners LP acquired a new position in shares of Chemed in the fourth quarter valued at $61,664,000. Point72 Asset Management L.P. bought a new position in Chemed in the fourth quarter worth $54,587,000. Finally, Raymond James Financial Inc. acquired a new stake in Chemed during the fourth quarter worth $42,023,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Stock Performance

Shares of NYSE:CHE traded up $2.80 during midday trading on Friday, reaching $558.68. 337,296 shares of the company's stock were exchanged, compared to its average volume of 106,623. The company's 50 day simple moving average is $564.50 and its two-hundred day simple moving average is $565.03. The firm has a market capitalization of $8.17 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 2.32 and a beta of 0.54. Chemed Corporation has a 12 month low of $512.12 and a 12 month high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.58% and a net margin of 12.40%. Chemed's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.20 EPS. On average, research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Investors of record on Thursday, May 29th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.36%. The ex-dividend date of this dividend was Thursday, May 29th. Chemed's dividend payout ratio is 9.74%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,500 shares of the business's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the sale, the chief executive officer now owns 101,197 shares of the company's stock, valued at $58,335,010.65. The trade was a 1.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold a total of 5,500 shares of company stock valued at $3,213,780 in the last 90 days. 3.29% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank Of Canada raised their price objective on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.